SCHEMBL8317152

SCHEMBL8317152

Cc1cc2nsnc2cc1N

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN11 Q06124 7/20 0.61
MEN1 O00255 5/20 0.61
KMT2A Q03164 5/20 0.61
MAPT P10636 4/20 0.61
ALDH1A1 P00352 4/20 0.61
APAF1 O14727 2/20 0.61
POLB P06746 1/20 0.61
THRB P10828 1/20 0.61
NR4A1 P22736 1/20 0.61
RECQL P46063 1/20 0.61
BLM P54132 1/20 0.61
NPSR1 Q6W5P4 1/20 0.61
L3MBTL1 Q9Y468 1/20 0.61
TERT O14746 1/20 0.52
PTPN1 P18031 3/20 0.50
PTPN6 P29350 1/20 0.50
CYP3A4 P08684 1/20 0.46
TSHR P16473 1/20 0.46
MAPK1 P28482 1/20 0.46
NPC1 O15118 4/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL367773 0.82 PTPN11 (0.44) PTPN11MEN1KMT2AMAPTALDH1A1
SCHEMBL22529352 0.82 PTPN11 (0.68) PTPN11MEN1KMT2AMAPTALDH1A1
SCHEMBL31355408 0.77 TERT (0.73) MEN1KMT2AMAPTALDH1A1APAF1
SCHEMBL29657638 0.77 TERT (0.73) MEN1KMT2AMAPTALDH1A1APAF1
SCHEMBL2466326 0.77 TERT (0.73) MEN1KMT2AMAPTALDH1A1APAF1
SCHEMBL16572269 0.76 PTPN11 (0.56) PTPN11MEN1KMT2AMAPTALDH1A1
SCHEMBL13856389 0.76 PTPN11 (1.00) PTPN11MEN1KMT2AMAPTALDH1A1
SCHEMBL11204584 0.73 TERT (0.60) MEN1KMT2AMAPTALDH1A1APAF1
SCHEMBL3342033 0.73 TERT (0.54) MEN1KMT2AMAPTALDH1A1APAF1
SCHEMBL8807216 0.71 CD44 (0.41) PTPN11MEN1KMT2AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025049253-A1 BRIDGED CYCLE‑BASED INHIBITORS OF DNA‑DEPENDENT PROTEIN KINASE AND COMPOSITIONS AND APPLICATION IN GENE EDITING JUNO THERAPEUTICS, INC. (US) 2025-03-06 WO disclosed
CN-116406272-A DNA-PK selective inhibitor and preparation method and application thereof 首药控股(北京)股份有限公司 2023-07-07 CN disclosed
CN-113956272-A DNA-PK selective inhibitor and preparation method and application thereof 首药控股(北京)有限公司 2022-01-21 CN disclosed
EP-0733626-B1 N-(Benzofuranazyl)-arylsulphonamides and their analogues useful as endothelin-receptor-antagonists MERCK PATENT GMBH (DE) 1999-01-13 EP disclosed
EP-0885219-A1 N-(2,1,3-BENZOTHIA(OXA)DIAZOLYL)-SULPHONAMIDES HAVING AN ENDOTHELIN RECEPTOR ANTAGONISTIC EFFECT MERCK PATENT GmbH (DE) 1998-12-23 EP disclosed
US-5726194-A Endothelin receptor antagonists MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1998-03-10 US disclosed
WO-1997030996-A1 N-(2,1,3-BENZOTHIA(OXA)DIAZOLYL)-SULPHONAMIDES HAVING AN ENDOTHELIN RECEPTOR ANTAGONISTIC EFFECT MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 1997-08-28 WO disclosed
EP-0733626-A1 N-(Benzofuranazyl)-arylsulphonamides and their analogues useful as endothelin-receptor-antagonists MERCK PATENT GmbH (DE) 1996-09-25 EP disclosed